Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA
- 10 March 1994
- journal article
- review article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 169 (2) , 257-272
- https://doi.org/10.1016/0022-1759(94)90270-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Ganglioside expression on human malignant melanoma assessed by quantitative immune thin‐layer chromatographyInternational Journal of Cancer, 1993
- Severe acute axonal form of Guillain–Barré syndrome associated with IgG anti‐GD1a antibodiesMuscle & Nerve, 1992
- Antibody responses to ganglio-series gangliosides in different strains of inbred miceMolecular Immunology, 1992
- Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.Journal of Clinical Investigation, 1991
- Role of Gangliosides in Active Immunotherapy with Melanoma VaccineInternational Reviews of Immunology, 1991
- HUMAN MONOCLONAL ANTIBODY TO GANGLIOSIDE GM2 FOR MELANOMA TREATMENTThe Lancet, 1989
- Mouse monoclonal antibodies detecting disialogangliosides on mouse and human t lymphomasInternational Journal of Cancer, 1988
- Immunogenicity of melanoma‐associated gangliosides in cancer patientsInternational Journal of Cancer, 1985
- Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigensNature, 1985
- GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.The Journal of Experimental Medicine, 1982